quantisnow
FeedTopReportsPricing
⌘K
Live feed
09:00:00·122d
PRRelease
Albany International Corporation logo

Albany International Achieves U.S. Department of War CMMC Level 2 Certification for its Albany Engineered Composites Business Segment

AIN· Albany International Corporation
Consumer Discretionary
Original source

Companies

  • AIN
    Albany International Corporation
    Consumer Discretionary

Recent analyst ratings

  • Aug 1UpdateTruist$55.00
  • Jul 31UpdateRobert W. Baird$79.00
  • Mar 28UpdateBofA Securities$95.00
  • Sep 18UpdateTD Cowen$106.00
  • Jul 14UpdateRobert W. Baird$120.00
  • Apr 27UpdateTruist$105.00

Related

  • PR7d
    Albany International Schedules First-Quarter 2026 Earnings Release and Conference Call
  • PR17d
    Albany Engineered Composites Named One of America's Safest Companies
  • SEC21d
    SEC Form DEF 14A filed by Albany International Corporation
  • SEC28d
    Amendment: SEC Form SCHEDULE 13G/A filed by Albany International Corporation
  • PR42d
    Albany International Announces Participation at the 2026 J.P. Morgan Industrials Conference
  • PR43d
    Albany International Selected as an Official Partner for World Engineering Day for Sustainable Development 2026
  • INSIDER51d
    President MC Stein Merle A converted options into 3,741 shares, returned $105,730 worth of shares to the company (1,834 units at $57.65) and covered exercise/tax liability with 656 shares, increasing direct ownership by 246% to 1,759 units (SEC Form 4)
  • INSIDER51d
    Senior Vice President & CTO Hansen Robert Alan returned $161,420 worth of shares to the company (2,800 units at $57.65), covered exercise/tax liability with 128 shares and converted options into 3,177 shares (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022